Showing posts with label new generic drugs. Show all posts
Showing posts with label new generic drugs. Show all posts

Friday, March 21, 2008

Acme Issues Voluntary Recall for Acme Labeled Cinnamon Rolls with Icing

Update : 1
Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page CDRH Home Page Search A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological HealthQuestions?
horizonal rule
CDRHNEW LogoDate: March 20, 2008

The following new items were added to the CDRH web pages on March 19, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

*PMA Final Decisions for February 2008Text

---


Update : 2

Subject: Acme Issues Voluntary Recall for Acme Labeled Cinnamon Rolls with Icing (March 18)

Acme Issues Voluntary Recall for Acme Labeled Cinnamon Rolls with Icing (March 18)
Thu, 20 Mar 2008 06:38:00 -0500

Acme Markets is issuing a voluntary recall on all codes of Acme label 4-pack cinnamon rolls with icing due to the undeclared milk ingredient. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product. The recall affects all Acme locations in New Jersey, Pennsylvania, Delaware and Maryland.


Update : 3
Subject: FDA Data Standards Update - FDA Data Standards Update - SPL Terminology Update

Greetings,

The FDA Data Standards Council's SPL web page was updated Thursday, March 20, 2008, to include an additional FDA preferred term and NCI Concept Code under Business Operations:

United States Agent - C73330

The new term and code are located on this web page: http://www.fda.gov/oc/datacouncil/term.html#busop.

Lonnie Smith

Project Manager

Food and Drug Administration


Update : 4
Subject: CDER New March 19

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 19, 2008


Update : 5
Subject: CDER New March 20

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 20, 2008

New and Generic Drug Approvals
  • Cefepime Hydochloride Injection, ACS Dobfar, Approval
  • Levitra (vardenafil hydrochloride) Tablets, Bayer Healthcare, Inc., Labeling Revision
  • TREANDA (bendamustine hydrochloride) Injection, Cephalon, Approval



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Tuesday, March 18, 2008

SPL Release Four Evaluation Material for Registration & Listing

Update : 1

Subject: FDA Data Standards Update - SPL Release Four Evaluation Material for Registration & Listing

Greetings,

The zip file containing the SPL Release Four evaluation material for registration and listing was updated Saturday, March 15, 2008, to include an additional document: SPL for Registration and Listing v0.2.

SPL Release Four Evaluation Material for Registration and Listing - http://www.fda.gov/oc/datacouncil/SPL_r4_registration_and_listing_material_v0.3.zip

Lonnie Smith

Project Manager

Food and Drug Administration


Update : 2

Subject: CDER's Small Business Assistance Workshop

Registration is open now. To register, call Saira Roberts at 214-860-5887. Space is limited to 150 participants. We appreciate advance notice of cancellations or replacements. Registration on the day of the event may be possible on a space availability basis. For more information, call Saira Roberts at 214-860-5887 or David Arvelo at 214-253-4952 or david.arvelo@fda.hhs.gov.

http://www.fda.gov/cder/about/smallbiz/SBAworkshop2008.htm


Update : 3

Subject: CDER New 3/17/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 17, 2008




This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Saturday, March 15, 2008

New and Generic Drug Approval, Medication errors,

Update : 1


Subject: CDER New 3/13/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 13, 2008


Update : 2

Subject: Slade Gorton and Co. Recalls Icybay Cooked Langostinos Because of Possible Health Risk (March 14)

Slade Gorton and Co. Recalls Icybay Cooked Langostinos Because of Possible Health Risk (March 14)
Fri, 14 Mar 2008 12:48:00 -0500

The product retails in one pound, clear plastic package marked with UPC 0-73129-61672-8 on the top and with an expiration date of June 2009 and is distributed under the brand name of "ICYBAY". The product also was distributed to wholesale accounts, also under the "ICYBAY" brand, in five pound clear plastic packages containing either 70-90 count, 90-125 count or 120-150 count. This recall involves production dates of July 18, 2007 through August 13, 2007 and/or Julian dates of 199 through 232.


Update : 3

Subject: FDA 101: Medication Errors

FDA 101: Medication Errors
Fri, 14 Mar 2008 13:08:00 -0500

There have been adverse events and deaths in children and adults due to the misuse of Tussionex, a long-acting prescription cough medicine. Learn more about this and other medication errors that have been reported to FDA.


Update : 4

Subject: FDA Takes Next Step in Establishing Overseas Presence

FDA Takes Next Step in Establishing Overseas Presence
Fri, 14 Mar 2008 18:00:00 -0500

In an important development, the U.S. Food and Drug Administration has received approval from the U.S. State Department to establish eight full time permanent FDA positions at U.S. diplomatic posts in the People's Republic of China, pending authorization from the Chinese government.



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Friday, March 14, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin : CDER New 3/11 & 12/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 12, 2008

March 11, 2008


Update : 2

Subject: Enforcement Report for March 12, 2008

Enforcement Report for March 12, 2008
Tue, 13 Mar 2007 07:08:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update : 3

Subject: Oncology Drugs Update: New Approval for Bevacizumab (Avastin)

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

On February 22, 2008, the U.S. Food and Drug Administration granted accelerated approval for bevacizumab (Avastin, Genentech, Inc.) to be used in combination with paclitaxel for the treatment of patients who have not received chemotherapy for metastatic HER2 negative breast cancer. More information at http://www.fda.gov/cder/Offices/OODP/whatsnew/bevacizumab200802.htm


Update : 4

Subject: Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Overview Version.

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Overview Version.
Thu, 13 Mar 2008 16:00:00 -0500

Hydrocodone, the narcotic ingredient in this medicine that controls cough, can cause life-threatening breathing problems and death when given above or more frequently than the recommended dose. Tussionex should not be used in children less than 6 years old. Overview Version.


Update : 5

Subject: Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Full Version.

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Full Version.
Thu, 13 Mar 2008 16:00:00 -0500

Hydrocodone, the narcotic ingredient in this medicine that controls cough, can cause life-threatening breathing problems and death when given above or more frequently than the recommended dose. Tussionex should not be used in children less than 6 years old. Full Version.



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420